These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 19144981

  • 1. Studies of the immune response in heparin-induced thrombocytopenia.
    Warkentin TE, Sheppard JA, Moore JC, Cook RJ, Kelton JG.
    Blood; 2009 May 14; 113(20):4963-9. PubMed ID: 19144981
    [Abstract] [Full Text] [Related]

  • 2. The temporal profile of the anti-PF4/heparin immune response.
    Greinacher A, Kohlmann T, Strobel U, Sheppard JA, Warkentin TE.
    Blood; 2009 May 14; 113(20):4970-6. PubMed ID: 19109231
    [Abstract] [Full Text] [Related]

  • 3. Incidence and clinical significance of anti-PF4/heparin antibodies of the IgG, IgM, and IgA class in 755 consecutive patient samples referred for diagnostic testing for heparin-induced thrombocytopenia.
    Juhl D, Eichler P, Lubenow N, Strobel U, Wessel A, Greinacher A.
    Eur J Haematol; 2006 May 14; 76(5):420-6. PubMed ID: 16466367
    [Abstract] [Full Text] [Related]

  • 4. Early-onset and persisting thrombocytopenia in post-cardiac surgery patients is rarely due to heparin-induced thrombocytopenia, even when antibody tests are positive.
    Selleng S, Malowsky B, Strobel U, Wessel A, Ittermann T, Wollert HG, Warkentin TE, Greinacher A.
    J Thromb Haemost; 2010 Jan 14; 8(1):30-6. PubMed ID: 19793190
    [Abstract] [Full Text] [Related]

  • 5. Incidence and clinical relevance of anti-platelet factor 4/heparin antibodies before cardiac surgery.
    Selleng S, Malowsky B, Itterman T, Bagemühl J, Wessel A, Wollert HG, Warkentin TE, Greinacher A.
    Am Heart J; 2010 Aug 14; 160(2):362-9. PubMed ID: 20691844
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Platelet-Activating Antibodies Are Detectable at the Earliest Onset of Heparin-Induced Thrombocytopenia, With Implications for the Operating Characteristics of the Serotonin-Release Assay.
    Warkentin TE, Arnold DM, Kelton JG, Sheppard JI, Smith JW, Nazy I.
    Chest; 2018 Jun 14; 153(6):1396-1404. PubMed ID: 29325985
    [Abstract] [Full Text] [Related]

  • 9. 5B9, a monoclonal antiplatelet factor 4/heparin IgG with a human Fc fragment that mimics heparin-induced thrombocytopenia antibodies.
    Kizlik-Masson C, Vayne C, McKenzie SE, Poupon A, Zhou Y, Champier G, Pouplard C, Gruel Y, Rollin J.
    J Thromb Haemost; 2017 Oct 14; 15(10):2065-2075. PubMed ID: 28771917
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Characterization of platelet factor 4 amino acids that bind pathogenic antibodies in heparin-induced thrombocytopenia.
    Huynh A, Arnold DM, Kelton JG, Smith JW, Horsewood P, Clare R, Guarné A, Nazy I.
    J Thromb Haemost; 2019 Feb 14; 17(2):389-399. PubMed ID: 30582672
    [Abstract] [Full Text] [Related]

  • 14. Determination of heparin-platelet factor 4-IgG antibodies improves diagnosis of heparin-induced thrombocytopenia.
    Lindhoff-Last E, Gerdsen F, Ackermann H, Bauersachs R.
    Br J Haematol; 2001 Jun 14; 113(4):886-90. PubMed ID: 11442479
    [Abstract] [Full Text] [Related]

  • 15. Cellular immune responses to platelet factor 4 and heparin complexes in patients with heparin-induced thrombocytopenia.
    Nazy I, Clare R, Staibano P, Warkentin TE, Larché M, Moore JC, Smith JW, Whitlock RP, Kelton JG, Arnold DM.
    J Thromb Haemost; 2018 Jul 14; 16(7):1402-1412. PubMed ID: 29723924
    [Abstract] [Full Text] [Related]

  • 16. Antibodies from patients with heparin-induced thrombocytopenia/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells.
    Visentin GP, Ford SE, Scott JP, Aster RH.
    J Clin Invest; 1994 Jan 14; 93(1):81-8. PubMed ID: 8282825
    [Abstract] [Full Text] [Related]

  • 17. Prevalence, isotype, and functionality of antiheparin-platelet factor 4 antibodies in patients treated with heparin and clinically suspected for heparin-induced thrombocytopenia. The pathogenic role of IgG.
    Untch B, Ahmad S, Jeske WP, Messmore HL, Hoppensteadt DA, Walenga JM, Lietz H, Fareed J.
    Thromb Res; 2002 Jan 15; 105(2):117-23. PubMed ID: 11958801
    [Abstract] [Full Text] [Related]

  • 18. Beneficial effect of exogenous platelet factor 4 for detecting pathogenic heparin-induced thrombocytopenia antibodies.
    Vayne C, Guery EA, Kizlik-Masson C, Rollin J, Bauters A, Gruel Y, Pouplard C.
    Br J Haematol; 2017 Dec 15; 179(5):811-819. PubMed ID: 29048130
    [Abstract] [Full Text] [Related]

  • 19. Clinical evaluation of acute systemic reaction and detection of IgG antibodies against PF4/heparin complexes in hemodialysis patients.
    Matsuo T, Wanaka K, Miyasita K, Prechel M, Walenga JM.
    Thromb Res; 2012 Apr 15; 129(4):474-8. PubMed ID: 22088491
    [Abstract] [Full Text] [Related]

  • 20. Anti-PF4-heparin immunoglobulin G is the major class of heparin-induced thrombocytopenia antibody: findings of an enzyme-linked immunofiltration assay using membrane-bound hPF4-heparin.
    Vun CM, Evans S, Chesterman CN.
    Br J Haematol; 2001 Jan 15; 112(1):69-75. PubMed ID: 11167786
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.